|Assessment process complete
|For the management of acute moderate to severe post-operative pain in adult patients.
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Full Pharmacoeconomic Evaluation Recommended.
|Full pharmacoeconomic assessment commissioned by HSE
|Pre-submission consultation with Applicant
|Full submission received from Applicant
|Additional follow-up to Preliminary Review sent to Applicant
|NCPE assessment outcome
|The assessment of sufentanil (Zalviso®) has been discontinued as the company has made a decision not to commercialise sufentanil in Ireland. 27/06/2018